It has been proved that activating AMPK can improve cardiometabolic disease [7], protect from myocardial ischemia [7], inhibit cardiac hypertrophy and cardiomyopathy [8,59–61], protect heart function and delay heart failure [7,62–65], and antiarrhythmia [10]. Here, PRKAA2 is linked to cardiac hypertrophy.